BR100 Increased By (0.66%)
BR30 Increased By (0.37%)
KSE100 Increased By (0.46%)
KSE30 Increased By (0.45%)
AGHA 7.78 Increased By ▲ 0.03 (0.39%)
BECO 5.20 Increased By ▲ 0.01 (0.19%)
BML 58.19 Decreased By ▼ -0.47 (-0.8%)
BOP 34.16 Increased By ▲ 0.47 (1.4%)
CNERGY 10.62 Increased By ▲ 0.01 (0.09%)
CSIL 5.43 Increased By ▲ 0.13 (2.45%)
FCCL 54.62 Increased By ▲ 0.88 (1.64%)
FFL 16.67 Increased By ▲ 0.21 (1.28%)
FNEL 1.27 Increased By ▲ 0.05 (4.1%)
KEL 7.40 Increased By ▲ 0.12 (1.65%)
KOSM 5.79 Increased By ▲ 0.15 (2.66%)
LOTCHEM 29.69 Increased By ▲ 0.04 (0.13%)
MLCF 95.25 Decreased By ▼ -1.11 (-1.15%)
NBP 203.71 Increased By ▲ 0.18 (0.09%)
NCPL 57.80 Increased By ▲ 0.95 (1.67%)
NPL 69.01 Increased By ▲ 1.70 (2.53%)
OGDC 316.51 Decreased By ▼ -1.71 (-0.54%)
PACE 10.71 Increased By ▲ 0.08 (0.75%)
PAEL 42.85 Increased By ▲ 1.08 (2.59%)
PIBTL 16.81 No Change ▼ 0.00 (0%)
PPL 220.05 Decreased By ▼ -0.12 (-0.05%)
PRL 50.80 Increased By ▲ 1.75 (3.57%)
PTC 70.62 Increased By ▲ 0.61 (0.87%)
SSGC 28.50 Decreased By ▼ -0.64 (-2.2%)
TBL 9.87 Increased By ▲ 0.10 (1.02%)
TELE 8.86 Increased By ▲ 0.04 (0.45%)
TPL 18.30 Increased By ▲ 1.13 (6.58%)
TPLP 12.89 Increased By ▲ 0.38 (3.04%)
TREET 22.65 Increased By ▲ 0.06 (0.27%)
TRG 59.92 Decreased By ▼ -0.30 (-0.5%)
World

AstraZeneca says it will work with Dutch over vaccine queries

  • "Regulatory authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," a spokesman for AstraZeneca said in a statement.
Published Updated
By

LONDON: AstraZeneca said on Friday it was working with Dutch authorities to address any questions they had after the Netherlands temporarily suspended use of its COVID-19 vaccine for people under 60 following the death of a woman who had received a shot.

"Regulatory authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," a spokesman for AstraZeneca said in a statement.

"Tens of millions of people have now received our vaccine across the globe. The extensive body of data from two large clinical datasets and real-world evidence demonstrate its effectiveness, reaffirming the role the vaccine can play during this public health crisis."

Comments

Comments are closed for this article.